ID   BXG_CLOBO               Reviewed;        1297 AA.
AC   Q60393;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 140.
DE   RecName: Full=Botulinum neurotoxin type G;
DE            Short=BoNT/G {ECO:0000303|PubMed:8268233};
DE   AltName: Full=Bontoxilysin-G;
DE   Contains:
DE     RecName: Full=Botulinum neurotoxin G light chain;
DE              Short=LC;
DE              EC=3.4.24.69 {ECO:0000269|PubMed:7910017};
DE   Contains:
DE     RecName: Full=Botulinum neurotoxin G heavy chain;
DE              Short=HC;
DE   Flags: Precursor;
GN   Name=botG;
OS   Clostridium botulinum.
OC   Bacteria; Firmicutes; Clostridia; Eubacteriales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=1491;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=113 / 30 / NCFB 3012 / Type G;
RX   PubMed=8268233; DOI=10.1016/0167-4781(93)90020-e;
RA   Campbell K., Collins M.D., East A.K.;
RT   "Nucleotide sequence of the gene coding for Clostridium botulinum
RT   (Clostridium argentinense) type G neurotoxin: genealogical comparison with
RT   other clostridial neurotoxins.";
RL   Biochim. Biophys. Acta 1216:487-491(1993).
RN   [2]
RP   IDENTIFICATION OF TOXIN, SUBCELLULAR LOCATION (BOTULINUM NEUROTOXIN TYPE
RP   G), HOST RANGE, EPIDEMIOLOGY, AND POSSIBLE RELEASE AS SINGLE CHAIN.
RC   STRAIN=89 / BL 1353 /Type G;
RX   PubMed=4922309;
RA   Gimenez D.F., Ciccarelli A.S.;
RT   "Another type of Clostridium botulinum.";
RL   Zentralbl. Bakteriol. 215:221-224(1970).
RN   [3]
RP   SUBCELLULAR LOCATION (BOTULINUM NEUROTOXIN TYPE G), HOST RANGE,
RP   EPIDEMIOLOGY, AND POSSIBLE RELEASE AS SINGLE CHAIN.
RC   STRAIN=89 / BL 1353 /Type G;
RX   PubMed=74236; DOI=10.1128/aem.34.6.843-848.1977;
RA   Ciccarelli A.S., Whaley D.N., McCroskey L.M., Gimenez D.F.,
RA   Dowell V.R. Jr., Hatheway C.L.;
RT   "Cultural and physiological characteristics of Clostridium botulinum type G
RT   and the susceptibility of certain animals to its toxin.";
RL   Appl. Environ. Microbiol. 34:843-848(1977).
RN   [4]
RP   HOST RANGE, AND EPIDEMIOLOGY.
RX   DOI=10.1099/00207713-38-4-375;
RA   Sue J.C., Hatheway C.L., Steigerwalt A.G., Brenner D.J.;
RT   "Clostridium argentinense sp. nov.: a genetically homogeneous group
RT   composed of all Strains of Clostridium botulinum toxin type G and some
RT   nontoxigenic strains previously identified as Clostridium subterminale or
RT   Clostridium hastiforme.";
RL   Int. J. Syst. Bacteriol. 38:375-381(1988).
RN   [5]
RP   FUNCTION (BOTULINUM NEUROTOXIN G LIGHT CHAIN), IDENTIFICATION OF SUBSTRATE,
RP   CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION (BOTULINUM NEUROTOXIN G LIGHT
RP   CHAIN).
RX   PubMed=7910017; DOI=10.1006/bbrc.1994.1526;
RA   Yamasaki S., Binz T., Hayashi T., Szabo E., Yamasaki N., Eklund M.,
RA   Jahn R., Niemann H.;
RT   "Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat
RT   synaptobrevin 2.";
RL   Biochem. Biophys. Res. Commun. 200:829-835(1994).
RN   [6]
RP   FUNCTION (BOTULINUM NEUROTOXIN TYPE G AND BOTULINUM NEUROTOXIN G HEAVY
RP   CHAIN), IDENTIFICATION OF HOST RECEPTOR (BOTULINUM NEUROTOXIN TYPE G), AND
RP   INTERACTION WITH HOST SYT1 AND SYT2.
RC   STRAIN=Type G;
RX   PubMed=15123599; DOI=10.1074/jbc.m403945200;
RA   Rummel A., Karnath T., Henke T., Bigalke H., Binz T.;
RT   "Synaptotagmins I and II act as nerve cell receptors for botulinum
RT   neurotoxin G.";
RL   J. Biol. Chem. 279:30865-30870(2004).
RN   [7]
RP   FUNCTION (BOTULINUM NEUROTOXIN B HEAVY CHAIN), INTERACTION WITH HOST SYT1
RP   AND SYT2, AND MUTAGENESIS OF MET-1126; LEU-1191; GLN-1200; TYR-1262 AND
RP   TRP-1268.
RC   STRAIN=Type G;
RX   PubMed=17185412; DOI=10.1073/pnas.0609713104;
RA   Rummel A., Eichner T., Weil T., Karnath T., Gutcaits A., Mahrhold S.,
RA   Sandhoff K., Proia R.L., Acharya K.R., Bigalke H., Binz T.;
RT   "Identification of the protein receptor binding site of botulinum
RT   neurotoxins B and G proves the double-receptor concept.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:359-364(2007).
RN   [8]
RP   FUNCTION (BOTULINUM NEUROTOXIN TYPE G), FUNCTION (BOTULINUM NEUROTOXIN G
RP   HEAVY CHAIN), AND MUTAGENESIS OF GLN-1200 AND TRP-1268.
RX   PubMed=19650874; DOI=10.1111/j.1471-4159.2009.06298.x;
RA   Rummel A., Haefner K., Mahrhold S., Darashchonak N., Holt M., Jahn R.,
RA   Beermann S., Karnath T., Bigalke H., Binz T.;
RT   "Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding
RT   site prior to stimulation-dependent uptake with botulinum neurotoxin F
RT   utilising the three isoforms of SV2 as second receptor.";
RL   J. Neurochem. 110:1942-1954(2009).
RN   [9] {ECO:0007744|PDB:1ZB7}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-443 IN COMPLEX WITH ZINC, AND
RP   COFACTOR.
RX   PubMed=16008342; DOI=10.1021/bi0505924;
RA   Arndt J.W., Yu W., Bi F., Stevens R.C.;
RT   "Crystal structure of botulinum neurotoxin type G light chain: serotype
RT   divergence in substrate recognition.";
RL   Biochemistry 44:9574-9580(2005).
RN   [10] {ECO:0007744|PDB:3MPP}
RP   X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 867-1297, FUNCTION (BOTULINUM
RP   NEUROTOXIN B HEAVY CHAIN), DOMAIN, GANGLIOSIDE-BINDING, AND MUTAGENESIS OF
RP   1080-SER--TRP-1084.
RC   STRAIN=Type G;
RX   PubMed=20507178; DOI=10.1021/bi100412v;
RA   Schmitt J., Karalewitz A., Benefield D.A., Mushrush D.J., Pruitt R.N.,
RA   Spiller B.W., Barbieri J.T., Lacy D.B.;
RT   "Structural analysis of botulinum neurotoxin type G receptor binding.";
RL   Biochemistry 49:5200-5205(2010).
RN   [11] {ECO:0007744|PDB:2VXR}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 863-1297, FUNCTION (BOTULINUM
RP   NEUROTOXIN B HEAVY CHAIN), SUBUNIT, AND DOMAIN.
RC   STRAIN=Type G;
RX   PubMed=20219474; DOI=10.1016/j.jmb.2010.02.041;
RA   Stenmark P., Dong M., Dupuy J., Chapman E.R., Stevens R.C.;
RT   "Crystal structure of the botulinum neurotoxin type G binding domain:
RT   insight into cell surface binding.";
RL   J. Mol. Biol. 397:1287-1297(2010).
CC   -!- FUNCTION: [Botulinum neurotoxin type G]: Botulinum toxin causes flaccid
CC       paralysis by inhibiting neurotransmitter (acetylcholine) release from
CC       the presynaptic membranes of nerve terminals of the eukaryotic host
CC       skeletal and autonomic nervous system, with frequent heart or
CC       respiratory failure (PubMed:15123599). Precursor of botulinum
CC       neurotoxin G which has 2 coreceptors; complex polysialylated
CC       gangliosides found on neural tissue and specific membrane-anchored
CC       proteins found in synaptic vesicles (PubMed:15123599). Receptor
CC       proteins are exposed on host presynaptic cell membrane during
CC       neurotransmitter release, when the toxin heavy chain (HC) binds to
CC       them. Upon synaptic vesicle recycling the toxin is taken up via the
CC       endocytic pathway. When the pH of the toxin-containing endosome drops a
CC       structural rearrangement occurs so that the N-terminus of the HC forms
CC       pores that allows the light chain (LC) to translocate into the cytosol.
CC       Once in the cytosol the disulfide bond linking the 2 subunits is
CC       reduced and LC cleaves its target protein on synaptic vesicles,
CC       preventing their fusion with the cytoplasmic membrane and thus
CC       neurotransmitter release (By similarity). Binds to host peripheral
CC       neuronal presynaptic membranes via synaptotagmins 1 and 2 (SYT1 and
CC       SYT2) (PubMed:15123599). Toxin binds to the membrane proximal extra-
CC       cytoplasmic region of SYT1 and SYT2 that is transiently exposed outside
CC       of cells during exocytosis; exogenous gangliosides do not enhance
CC       binding and subsequent uptake of toxin into host cells
CC       (PubMed:15123599). Toxin activity can be blocked by the appropriate
CC       synaptotagmin protein fragments in cell culture (PubMed:15123599).
CC       {ECO:0000250|UniProtKB:P0DPI0, ECO:0000269|PubMed:15123599}.
CC   -!- FUNCTION: [Botulinum neurotoxin G light chain]: Has proteolytic
CC       activity. After translocation into the eukaryotic host cytosol acts as
CC       a zinc endopeptidase that cleaves synaptobrevins-1, -2 and -3 (also
CC       called VAMP1, VAMP2 and VAMP3) (PubMed:7910017). Hydrolyzes the '81-
CC       Ala-|-Ala-82' bond of VAMP2, and probably also the equivalent 'Ala-|-
CC       Ala' sites in VAMP1 and VAMP3 (PubMed:7910017). Has low activity on
CC       A.californica synaptobrevin and none on D.melanogaster synaptobrevin or
CC       cellubrevin, have a slightly different sequence (PubMed:7910017).
CC       {ECO:0000269|PubMed:7910017}.
CC   -!- FUNCTION: [Botulinum neurotoxin G heavy chain]: Responsible for host
CC       cell targeting and translocation of light chain (LC) into host cytosol.
CC       Composed of 3 subdomains; the translocation domain (TD), and N-terminus
CC       and C-terminus of the receptor-binding domain (N-RBD, C-RBD). The RBD
CC       is responsible for the adherence of the toxin to the cell surface. It
CC       simultaneously recognizes 2 coreceptors; polysialated gangliosides and
CC       the receptor proteins SYT1 and SYT2 in close proximity on host synaptic
CC       vesicles (PubMed:17185412). The N-terminus of the TD wraps an extended
CC       belt around the perimeter of the LC, protecting Zn(2+) in the active
CC       site; it may also prevent premature LC dissociation from the
CC       translocation channel and protect toxin prior to translocation (By
CC       similarity). The TD inserts into synaptic vesicle membrane to allow
CC       translocation into the host cytosol (By similarity). Has 2 coreceptors;
CC       complex gangliosides found primarily on neural tissue and host
CC       synaptotagmin-1 and -2 (SYT1 and SYT2) which bind to separate sites at
CC       the tip of the HC (PubMed:17185412). HC alone binds to host receptors
CC       SYT1 and SYT2; C-RBD interacts with host SYT2 (PubMed:15123599). Has
CC       equal affinity for SYT1 and SYT2; gangliosides are not required for (or
CC       only very slightly improve) binding to a membrane-anchored receptor
CC       fragment (PubMed:17185412, PubMed:20219474). Has also been shown to
CC       only bind SYT1; the assay methods were different (PubMed:20507178).
CC       Binds ganglioside GT1b (PubMed:20507178). Significantly decreases
CC       uptake and toxicity of whole BoNT/B and BoNT/G (PubMed:19650874).
CC       {ECO:0000250|UniProtKB:P0DPI0, ECO:0000269|PubMed:15123599,
CC       ECO:0000269|PubMed:17185412, ECO:0000269|PubMed:19650874,
CC       ECO:0000269|PubMed:20219474, ECO:0000269|PubMed:20507178}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Limited hydrolysis of proteins of the neuroexocytosis
CC         apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on
CC         small molecule substrates.; EC=3.4.24.69;
CC         Evidence={ECO:0000269|PubMed:7910017};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:16008342};
CC       Note=Binds 1 zinc ion per subunit (PubMed:16008342).
CC       {ECO:0000269|PubMed:16008342};
CC   -!- SUBUNIT: Heterodimer; disulfide-linked heterodimer of a light chain
CC       (LC) and a heavy chain (HC). The LC has the proteolytic/pharmacological
CC       activity, while the N- and C-termini of the HC mediate channel
CC       formation and toxin binding, respectively. Interacts with host
CC       receptors synaptotagmin-1 and -2 (SYT1 and SYT2) (PubMed:15123599,
CC       PubMed:17185412, PubMed:20219474). {ECO:0000269|PubMed:15123599,
CC       ECO:0000269|PubMed:17185412, ECO:0000269|PubMed:20219474}.
CC   -!- SUBCELLULAR LOCATION: [Botulinum neurotoxin type G]: Secreted
CC       {ECO:0000269|PubMed:74236, ECO:0000305|PubMed:4922309}.
CC   -!- SUBCELLULAR LOCATION: [Botulinum neurotoxin G light chain]: Secreted
CC       {ECO:0000305|PubMed:74236}. Host cytoplasm, host cytosol
CC       {ECO:0000305|PubMed:7910017}.
CC   -!- SUBCELLULAR LOCATION: [Botulinum neurotoxin G heavy chain]: Secreted
CC       {ECO:0000305|PubMed:74236}. Host synapse, host presynaptic cell
CC       membrane {ECO:0000250|UniProtKB:P0DPI0}. Host cytoplasmic vesicle, host
CC       secretory vesicle, host synaptic vesicle membrane
CC       {ECO:0000250|UniProtKB:P0DPI0}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- DOMAIN: [Botulinum neurotoxin G light chain]: Has protease activity
CC       (PubMed:7910017). {ECO:0000269|PubMed:7910017}.
CC   -!- DOMAIN: [Botulinum neurotoxin G heavy chain]: Has 3 functional domains.
CC       The translocation domain (TD) which probably forms membrane channels to
CC       allow light chain (LC) into the host cytosol (Probable). The C-terminal
CC       receptor-binding domain (RBD) has 2 further subdomains, N-RBD (Hcn) and
CC       C-RBD (Hcc) (PubMed:20507178, PubMed:20219474). The N-terminus of the
CC       TD wraps an extended belt around the perimeter of the LC, protecting
CC       Zn(2+) in the active site and may be a pseudosubstrate inhibitor which
CC       serves as an intramolecular chaperone for the LC prior to its
CC       translocation into the host cytosol (By similarity). The RBD binds
CC       transiently exposed coreceptors on the host presynaptic cell membrane
CC       (Probable). {ECO:0000250|UniProtKB:P0DPI0, ECO:0000269|PubMed:20219474,
CC       ECO:0000269|PubMed:20507178, ECO:0000269|PubMed:7910017,
CC       ECO:0000305|PubMed:15123599}.
CC   -!- MISCELLANEOUS: There are seven antigenically distinct forms of
CC       botulinum neurotoxin: Types A, B, C, D, E, F, and G; new subtypes are
CC       quite frequent.
CC   -!- MISCELLANEOUS: Botulism poisoning is usually food-borne, either by
CC       ingesting toxin or bacterial-contaminated food, or less frequently by
CC       inhalation poisoning. In both cases the neurotoxin binds to the apical
CC       surface of epithelial cells in the gut or airway. Toxin undergoes
CC       receptor-mediated endocytosis (using a different receptor than on
CC       target nerve cells), transcytosis across the epithelial cells and
CC       release into the general circulation. Once in the general circulation
CC       it binds to its target cells. {ECO:0000250|UniProtKB:P0DPI0}.
CC   -!- MISCELLANEOUS: Type G toxin has been isolated from soil samples and
CC       human autopsy specimens but has not been clearly implicated as the
CC       cause of human paralytic illness or death (Ref.4). Strain 89 was
CC       isolated from soil in Mendoza province, Argentiana (PubMed:4922309).
CC       Administration of strain 89 toxin to mouse, chicken, guinea pig and
CC       rhesus monkeys causes botulism symptoms and in most cases death, while
CC       dog and sheep show no signs of botulism (PubMed:74236). In the original
CC       report 5-fold higher levels of toxin caused botulism and death in sheep
CC       (PubMed:4922309). {ECO:0000269|PubMed:4922309,
CC       ECO:0000269|PubMed:74236, ECO:0000305|Ref.4}.
CC   -!- MISCELLANEOUS: Trypsinization of purified toxin increases its toxicity,
CC       suggesting it is released as a single chain (PubMed:4922309,
CC       PubMed:74236). {ECO:0000305|PubMed:4922309, ECO:0000305|PubMed:74236}.
CC   -!- SIMILARITY: Belongs to the peptidase M27 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=BotDB - A Database Resource for Clostridial
CC       Neurotoxins;
CC       URL="https://botdb.abcc.ncifcrf.gov/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X74162; CAA52275.1; -; Genomic_DNA.
DR   PIR; S39791; S39791.
DR   PDB; 1ZB7; X-ray; 2.35 A; A=1-443.
DR   PDB; 2VXR; X-ray; 1.90 A; A=863-1297.
DR   PDB; 3MPP; X-ray; 1.98 A; G=867-1297.
DR   PDBsum; 1ZB7; -.
DR   PDBsum; 2VXR; -.
DR   PDBsum; 3MPP; -.
DR   SMR; Q60393; -.
DR   DIP; DIP-60790N; -.
DR   IntAct; Q60393; 3.
DR   MINT; Q60393; -.
DR   DrugBank; DB13899; Equine Botulinum Neurotoxin G Immune FAB2.
DR   MEROPS; M27.002; -.
DR   UniLectin; Q60393; -.
DR   ABCD; Q60393; 27 sequenced antibodies.
DR   BRENDA; 3.4.24.69; 1462.
DR   Reactome; R-HSA-5250989; Toxicity of botulinum toxin type G (botG).
DR   EvolutionaryTrace; Q60393; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044161; C:host cell cytoplasmic vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0044164; C:host cell cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0044156; C:host cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0044231; C:host cell presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008320; F:protein transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0046929; P:negative regulation of neurotransmitter secretion; IEA:InterPro.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1120.10; -; 1.
DR   InterPro; IPR000395; Bot/tetX_LC.
DR   InterPro; IPR036248; Clostridium_toxin_transloc.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011065; Kunitz_inhibitor_STI-like_sf.
DR   InterPro; IPR013104; Toxin_rcpt-bd_C.
DR   InterPro; IPR012928; Toxin_rcpt-bd_N.
DR   InterPro; IPR012500; Toxin_trans.
DR   Pfam; PF01742; Peptidase_M27; 1.
DR   Pfam; PF07951; Toxin_R_bind_C; 1.
DR   Pfam; PF07953; Toxin_R_bind_N; 1.
DR   Pfam; PF07952; Toxin_trans; 1.
DR   PRINTS; PR00760; BONTOXILYSIN.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF50386; SSF50386; 1.
DR   SUPFAM; SSF58091; SSF58091; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Host cell membrane; Host cytoplasm;
KW   Host cytoplasmic vesicle; Host membrane; Host synapse; Hydrolase;
KW   Lipid-binding; Membrane; Metal-binding; Metalloprotease; Neurotoxin;
KW   Protease; Secreted; Toxin; Virulence; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P0DPI0"
FT   CHAIN           2..1297
FT                   /note="Botulinum neurotoxin type G"
FT                   /id="PRO_0000444922"
FT   CHAIN           2..442
FT                   /note="Botulinum neurotoxin G light chain"
FT                   /id="PRO_0000029227"
FT   CHAIN           443..1297
FT                   /note="Botulinum neurotoxin G heavy chain"
FT                   /id="PRO_0000029228"
FT   REGION          446..862
FT                   /note="Translocation domain (TD)"
FT                   /evidence="ECO:0000250|UniProtKB:P0DPI0"
FT   REGION          488..537
FT                   /note="Belt"
FT                   /evidence="ECO:0000250|UniProtKB:P0DPI0"
FT   REGION          868..1073
FT                   /note="N-terminus of receptor binding domain (N-RBD)"
FT                   /evidence="ECO:0000269|PubMed:20219474,
FT                   ECO:0000269|PubMed:20507178"
FT   REGION          1089..1297
FT                   /note="C-terminus of receptor binding domain (C-RBD)"
FT                   /evidence="ECO:0000269|PubMed:20219474,
FT                   ECO:0000269|PubMed:20507178"
FT   MOTIF           1266..1269
FT                   /note="Host ganglioside-binding motif"
FT                   /evidence="ECO:0000305|PubMed:17185412"
FT   ACT_SITE        231
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         230
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:16008342, ECO:0007744|PDB:1ZB7"
FT   BINDING         234
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:16008342, ECO:0007744|PDB:1ZB7"
FT   BINDING         268
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:16008342,
FT                   ECO:0007744|PDB:1ZB7"
FT   SITE            1268
FT                   /note="Ganglioside-binding site"
FT                   /evidence="ECO:0000305|PubMed:17185412"
FT   DISULFID        436..450
FT                   /note="Interchain (between light and heavy chains)"
FT                   /evidence="ECO:0000250|UniProtKB:P0DPI0, ECO:0000305"
FT   MUTAGEN         1080..1084
FT                   /note="SSLYW->EERYK: Improves solubility of isolated heavy
FT                   chain (HC), used for crystallization."
FT                   /evidence="ECO:0000269|PubMed:20507178"
FT   MUTAGEN         1126
FT                   /note="M->D: Significantly decreased binding of HC to host
FT                   SYT1 and SYT2 independent of gangliosides."
FT                   /evidence="ECO:0000269|PubMed:17185412"
FT   MUTAGEN         1191
FT                   /note="L->R: Significantly decreased binding of HC to host
FT                   SYT1 and SYT2 independent of gangliosides."
FT                   /evidence="ECO:0000269|PubMed:17185412"
FT   MUTAGEN         1200
FT                   /note="Q->E: Significantly decreased binding of HC to host
FT                   SYT1 and SYT2 independent of gangliosides."
FT                   /evidence="ECO:0000269|PubMed:17185412"
FT   MUTAGEN         1200
FT                   /note="Q->K: Decreased binding of HC to host SYT1 and SYT2
FT                   independent of gangliosides; whole toxin is less toxic.
FT                   Dramatically decreased toxicity; when associated with
FT                   L-1268. HC no longer inhibits whole-toxin uptake and
FT                   toxicity."
FT                   /evidence="ECO:0000269|PubMed:17185412,
FT                   ECO:0000269|PubMed:19650874"
FT   MUTAGEN         1262
FT                   /note="Y->F: Slightly increased binding of HC to host SYT1
FT                   and SYT2 in presence of gangliosides."
FT                   /evidence="ECO:0000269|PubMed:17185412"
FT   MUTAGEN         1268
FT                   /note="W->L: Gangliosides no longer increase HC affinity
FT                   for SYT1 or SYT2; whole toxin about significantly less
FT                   toxic. Dramatically decreased toxicity; when associated
FT                   with K-1200. In mice without complex gangliosides no change
FT                   compared to wild-type protein. HC no longer inhibits
FT                   whole-toxin uptake and toxicity."
FT                   /evidence="ECO:0000269|PubMed:17185412,
FT                   ECO:0000269|PubMed:19650874"
FT   STRAND          16..23
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          28..30
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          34..40
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          69..74
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            76..79
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           82..99
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           103..114
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            134..136
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          137..142
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          150..155
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           182..184
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          199..208
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          215..221
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           224..239
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           266..273
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            277..279
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           282..303
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          308..313
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           316..327
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           341..353
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           357..364
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          377..381
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            388..390
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            393..395
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           400..402
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           406..411
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            413..415
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   HELIX           417..419
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   TURN            425..427
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          428..432
FT                   /evidence="ECO:0007829|PDB:1ZB7"
FT   STRAND          870..876
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          879..882
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          889..892
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          897..899
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          905..911
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          916..919
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   TURN            922..924
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          927..930
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          933..940
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   HELIX           946..948
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   HELIX           949..954
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          956..964
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          967..974
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          977..983
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          989..995
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          998..1002
FT                   /evidence="ECO:0007829|PDB:3MPP"
FT   STRAND          1010..1016
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1020..1026
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1029..1035
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1046..1054
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1061..1072
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   HELIX           1076..1086
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1097..1099
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1105..1113
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1116..1121
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   HELIX           1122..1124
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1126..1131
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1134..1136
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1141..1143
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1150..1155
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1174..1184
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1186..1191
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1196..1200
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1202..1206
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1216..1219
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1229..1236
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1239..1248
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1260..1267
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   HELIX           1268..1272
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1275..1277
FT                   /evidence="ECO:0007829|PDB:2VXR"
FT   STRAND          1286..1289
FT                   /evidence="ECO:0007829|PDB:2VXR"
SQ   SEQUENCE   1297 AA;  149146 MW;  306CF54CF3973C3B CRC64;
     MPVNIKXFNY NDPINNDDII MMEPFNDPGP GTYYKAFRII DRIWIVPERF TYGFQPDQFN
     ASTGVFSKDV YEYYDPTYLK TDAEKDKFLK TMIKLFNRIN SKPSGQRLLD MIVDAIPYLG
     NASTPPDKFA ANVANVSINK KIIQPGAEDQ IKGLMTNLII FGPGPVLSDN FTDSMIMNGH
     SPISEGFGAR MMIRFCPSCL NVFNNVQENK DTSIFSRRAY FADPALTLMH ELIHVLHGLY
     GIKISNLPIT PNTKEFFMQH SDPVQAEELY TFGGHDPSVI SPSTDMNIYN KALQNFQDIA
     NRLNIVSSAQ GSGIDISLYK QIYKNKYDFV EDPNGKYSVD KDKFDKLYKA LMFGFTETNL
     AGEYGIKTRY SYFSEYLPPI KTEKLLDNTI YTQNEGFNIA SKNLKTEFNG QNKAVNKEAY
     EEISLEHLVI YRIAMCKPVM YKNTGKSEQC IIVNNEDLFF IANKDSFSKD LAKAETIAYN
     TQNNTIENNF SIDQLILDND LSSGIDLPNE NTEPFTNFDD IDIPVYIKQS ALKKIFVDGD
     SLFEYLHAQT FPSNIENLQL TNSLNDALRN NNKVYTFFST NLVEKANTVV GASLFVNWVK
     GVIDDFTSES TQKSTIDKVS DVSIIIPYIG PALNVGNETA KENFKNAFEI GGAAILMEFI
     PELIVPIVGF FTLESYVGNK GHIIMTISNA LKKRDQKWTD MYGLIVSQWL STVNTQFYTI
     KERMYNALNN QSQAIEKIIE DQYNRYSEED KMNINIDFND IDFKLNQSIN LAINNIDDFI
     NQCSISYLMN RMIPLAVKKL KDFDDNLKRD LLEYIDTNEL YLLDEVNILK SKVNRHLKDS
     IPFDLSLYTK DTILIQVFNN YISNISSNAI LSLSYRGGRL IDSSGYGATM NVGSDVIFND
     IGNGQFKLNN SENSNITAHQ SKFVVYDSMF DNFSINFWVR TPKYNNNDIQ TYLQNEYTII
     SCIKNDSGWK VSIKGNRIIW TLIDVNAKSK SIFFEYSIKD NISDYINKWF SITITNDRLG
     NANIYINGSL KKSEKILNLD RINSSNDIDF KLINCTDTTK FVWIKDFNIF GRELNATEVS
     SLYWIQSSTN TLKDFWGNPL RYDTQYYLFN QGMQNIYIKY FSKASMGETA PRTNFNNAAI
     NYQNLYLGLR FIIKKASNSR NINNDNIVRE GDYIYLNIDN ISDESYRVYV LVNSKEIQTQ
     LFLAPINDDP TFYDVLQIKK YYEKTTYNCQ ILCEKDTKTF GLFGIGKFVK DYGYVWDTYD
     NYFCISQWYL RRISENINKL RLGCNWQFIP VDEGWTE
//
